Show simple item record

Evolución de un Linfoma No Hodgkin “Triple Expressor” en un paciente transplantado renal con quimioterapia DA-R-EPOCH. Caso Clínico

dc.contributoren-US
dc.contributorNingunaes-ES
dc.creatorAránguiz, Natalia; Servicio de Medicina, Sección Hematología, Hospital Dr. Gustavo Fricke, Viña del Mar, Chile. Servicio de Hemato-Oncología, Hospital Naval A Nef, Viña del Mar, Chile.
dc.creatorVega, Jorge; Escuela de Medicina Universidad de Valparaíso; Hospital Naval A. Nef; Hospital Dr. Gustavo Fricke
dc.date2019-01-18
dc.date.accessioned2019-11-11T18:28:15Z
dc.date.available2019-11-11T18:28:15Z
dc.identifierhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/6840
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/111487
dc.descriptionPatients transplanted from solid organs have an increased risk of cancer, especially lymphomas. Lymphomas correspond to 4 to 5% of malignant neoplasms in the general population and in solid organ transplant patients it reaches an incidence of 21%. The incidence of non-Hodgkin lymphomas is 10 times higher than in the non-transplanted population. We report the case of a 68-year-old man with a kidney transplant who 6 years after transplantation, developed a non-Hodgkin diffuse of large cells B lymphoma with lymph node and pulmonary involvement, with markers of very poor prognosis (triple MYC expressor, BCL2 and BCL6). and its evolution with chemotherapy with DA R EPOCH.en-US
dc.descriptionPatients transplanted from solid organs have an increased risk of cancer, especially lymphomas. Lymphomas correspond to 4 to 5% of malignant neoplasms in the general population and in solid organ transplant patients it reaches an incidence of 21%. The incidence of non-Hodgkin lymphomas is 10 times higher than in the non-transplanted population. We report the case of a 68-year-old man with a kidney transplant who 6 years after transplantation, developed a non-Hodgkin diffuse of large cells B lymphoma with lymph node and pulmonary involvement, with markers of very poor prognosis (triple MYC expressor, BCL2 and BCL6). and its evolution with chemotherapy with DA R EPOCH.es-ES
dc.formatapplication/pdf
dc.languagespa
dc.publisherRevista Médica de Chilees-ES
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/view/6840/4702
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6840/35535
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6840/35536
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6840/35573
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6840/35672
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6840/37595
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6840/37596
dc.relationhttp://www.revistamedicadechile.cl/ojs/index.php/rmedica/article/downloadSuppFile/6840/38619
dc.sourceRevista Médica de Chile; Vol. 147, núm. 2 (2019): FEBRERO 2019es-ES
dc.source0034-9887
dc.subjectDrug Therapy; Kidney Transplantation; Lymphoma, Non –Hodgkin; Lymphoproliferative Disordersen-US
dc.subjectDrug Therapy; Kidney Transplantation; Lymphoma, Non –Hodgkin; Lymphoproliferative Disorderses-ES
dc.titleTRIPLE EXPRESSOR LYMPHOMA IN A KIDNEY TRANSPLANT PATIENTen-US
dc.titleEvolución de un Linfoma No Hodgkin “Triple Expressor” en un paciente transplantado renal con quimioterapia DA-R-EPOCH. Caso Clínicoes-ES
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typees-ES


This item appears in the following Collection(s)

Show simple item record